Schedule 13D ownership disclosure
Immune Therapeutics Inc
Security class unavailable · CUSIP: 45252A107
Event date: 2021-05-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 12.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-21-031137
- Form type
- SC 13D
- Filer
- Griffin Noreen
- CIK
- CIK 1611517
- Filed
- Jun 07, 2021
- Reporting period
- May 28, 2021
- Description
- Schedule 13D beneficial ownership